Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: Outcomes analysis of the UNOS/OPTN database

American Journal of Transplantation

Volumn 11, Issue 8, 2011, Pages 1676-1685

  Irish, W D ^a   Arcona, S ^b   Bowers, D ^a   Trotter, J F ^c  

^a Health Outcomes Research and Biostatistics   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cyclosporine micro emulsion; hepatitis C virus; liver transplant; tacrolimus

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; COHORT STUDIES; CYCLOSPORINE; DATABASE MANAGEMENT SYSTEMS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TACROLIMUS; TREATMENT OUTCOME;

EID: 79961025286     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03508.x     Document Type: Article

References (18)

1. Wiesner RH, Sorrell M, Villamil F,. International liver transplantation society expert panel. Report of the first International liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 2003; 9: S1-9. (Pubitemid 37407996)
2. Watt K, Veldt B, Charlton M,. A practical guide to the management of HCV infection following liver transplantation. Am J Transplant 2009; 9: 1707-1713.
3. Nakagawa M, Sakamoto N, Enomoto N, et al,. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun 2004; 313: 42-47. (Pubitemid 37524022)
4. Berenguer M, Royuela A, Zamora J,. Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis. Liver Transpl 2007; 13: 21-29. (Pubitemid 46099970)
5. UNOS/OPTN. STAR liver transplant registry files. Registry files received October 5, 2009.
6. Kaplan EL, Meier P,. Nonprametric estimation of incomplete observations. J Am Statistical Assoc 1958; 53: 457-481.
7. Hosmer DW, Lemeshow S,. Applied logistic regression. New York: Wiley, 1989.
8. Normand ST, Landrum MB, Guadagnoli E, et al,. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores. J Clin Epidemiol 2001; 54: 387-398. (Pubitemid 32303462)
9. D'Agostino RB, Jr,. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281. (Pubitemid 28466823)
10. Rosenbaum PR, Rubin DB,. The bias due to incomplete matching. Biometrics 1985; 41: 103-116.
11. Lunceford JK, Davidian M,. Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study. Stat Med 2004; 23: 2937-2960. (Pubitemid 39200133)
12. Cox DR,. Regression models and life tables (with discussion). J R Statistics Soc Ser B 1972; 34: 187-220.
13. Hosmer DW, Lemeshow S,. Applied survival analysis. New York: Wiley, 1999.
14. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR,. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896. (Pubitemid 34267271)
15. Wiesner RH,. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: A report of the United States FK506 Study Group. Transplantation 1998; 66: 493-499. (Pubitemid 28415377)
16. Takemoto SK, Arns W, Bunnapradist S, et al,. Expanding the evidence base in transplantation: The complementary roles of randomized controlled trials and outcomes research. Transplantation 2008; 86: 18-25.
17. Gilmore AS, Helderman JH, Ricci JF, et al,. Linking the US transplant registry to administrative claims data: Expanding the potential of transplant research. Med Care 2007; 45: 529-536.
18. Stirnemann PM, Takemoto SK, Schnitzler MA, et al,. Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol 2006; 17: 2299-2306. (Pubitemid 44141921)